[Social and hygienic factors of pharmacological market in Russia].
Although there is a huge variety of medical drugs, the practitioner finds it sometimes difficult to choose an appropriate drug for his patient; the insurance companies, striving for maximal profits, do their best to make the treatment as cheap as possible and to limit the doctor in his choice of preparations; and the manufacturers, seeking to reduce the production costs and make as much profit as possible, give up the research projects and purchase lower-quality substances abroad, facilitate the technologies and neglect the stage-by-stage quality control. However, the inaccessibility of medical drugs due to their high prices (not all patients can allow buying the needed drugs, and there is also a danger that one can buy a counterfeit) still persists to be the key problem. The above stated leads to a poorer treatment quality and a lower status of the national health as a whole.